Insilico Medicine Snaps Up $60M to Create Robotic Lab of the Future
Hong Kong-based pioneer of the artificial intelligence (AI)-driven drug discovery, a clinical stage biotech Insilico Medicine, has completed a $60 …
Premium Articles
Tissue Selective E3 Ligase-based Degraders
The efficacy and selectivity of protein degrader drugs depend on their affinity to the target protein but also on the type …
Virtual Reality in Drug Discovery: More Useful Than You Probably Think
Using virtual reality (VR) for manipulating 3D models of small molecules and large biomolecules in the context of drug design …
Bioengineered Extracellular Vesicles - Potential Boon for Delivering Biotherapeutics
Because of endogenous properties, extracellular vesicles (EVs) have shown impressive potential as remedial modalities; nevertheless, more bioengineering refinement is expected …
Gearing AI to Fight Pandemics: a Novel COVID-19 Drug Candidate Announced
Hong Kong-based clinical stage drug discovery company Insilico Medicine just announced the nomination of a novel preclinical drug candidate for …
The Promise of Next-Generation Proteomics in Revolutionizing Cancer Research and Treatment
Artificial intelligence (AI) is undoubtedly a big deal in the pharmaceutical industry, bringing the unprecedented abilities of modeling biology at …
Meet the Company Using Artificial Intelligence for Designing Targeted Protein Degraders
Proteins are essential components of living matter – they function as building blocks for cells and tissues, as well as …
7 Biotechs Fighting Rare Diseases With Gene-Editing Tech
As of now, only 5% of so-called rare diseases (orphan diseases) have an FDA-approved treatment available to patients. Rare diseases …
Better Data Management is Key for Clinical Trials: Interview with Raj Indupuri, CEO, eClinical Solutions
The digitalization of clinical trials and the adoption of artificial intelligence (AI) has been a hot topic for a number …
Merging AI and Quantum Computing To Boost Drug Discovery
Quantum computing is a growing trend due to recent major advances in hardware making this technology a practically feasible thing. …
How Pharmaceutical Industry Is Adopting Artificial Intelligence To Boost Drug Research
What is “artificial intelligence”? Artificial intelligence (AI) is an interdisciplinary science concerned with building “intelligent agents”, the field which takes …
The Evolving Culture of Biotech Entrepreneurship
Dr. Tony Kulesa is the co-founder of Petri, an organization that both invests in early-stage biotech startups and works 1-on-1 …